Listed
Stock Code: 115180
| Company Name | (주)큐리언트 |
| English Name | Qurient Co., Ltd. |
| Business Reg. No. | 2098147197 |
| CEO | 남기연 |
| Address | 경기도 성남시 분당구 판교로 242, C동 8층 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 70113 |
| Established | 2008-07-02 |
| Phone | 031-8060-1600 |
| Website | www.qurient.com |
| Regular Employees | 30persons |
| Corp. Reg. No. | 1101113926875 |
Venture Certified
| 벤처투자유형 | 2010-06-10 ~ 2012-06-09 | 20100300166 | 2010-06-10 |
| 벤처투자유형 | 2012-06-10 ~ 2014-06-09 | 20120300207 | 2010-06-10 |
| 벤처투자유형 | 2014-07-24 ~ 2016-07-23 | 20140300273 | 2010-06-10 |
| 벤처투자유형 | 2016-07-24 ~ 2018-07-23 | 20160300330 | 2010-06-10 |
| 벤처투자유형 | 2018-07-24 ~ 2020-07-23 | 20180300542 | 2010-06-10 |
| 연구개발유형 | 2020-07-24 ~ 2022-07-23 | 20200402349 | 2010-06-10 |
| 벤처투자유형 | 2022-07-24 ~ 2025-07-23 | 20220713010002 | 2010-06-10 |
| 벤처투자유형 | 2025-07-24 ~ 2028-07-23 | 20250715010016 | 2010-06-10 |
Revenue CAGR -4.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 110B | 117B | 122B |
| Operating Profit | -251B | -201B | -230B |
| Net Profit | -223B | -195B | -227B |
| Total Assets | 636B | 488B | 325B |
| Total Liabilities | 53B | 25B | 31B |
| Total Equity | 582B | 463B | 294B |
Operating Loss: Op. profit -251B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+4pp YoY)
▼ 7.9%
▼ 16.7%
▼ 26.8%
▲ 15.2%
▲ 35.8%
| Name | Position | Role |
|---|---|---|
| 남기연 | 대표이사 | 대표 |
| NPS Subscribers | 30persons |
| CEO | 남기연 |
| Est. Avg. Annual Salary | 6,17610K (51510K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | 0persons |
| NPS Join Date | 2009-10-15 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
3 Additional Data Sources
{
"address": "경기도 성남시 분당구 판교로",
"brno": "209814****",
"cappedWarning": false,
"companyName": "주식회사 큐리언트",
"estimatedAvgAnnualSalary": 61755204,
"estimatedAvgMonthlySalary": 5146267,
"fetchedAt": "2026-03-05T22:03:39.731Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20091015",
"last12MonthsHired": 0,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 0,
"leaveDate": null,
"monthlyPensionAmount": 14666860,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6709494",
"status": "1",
"styleCode": "1",
"subscriberCount": 30,
"turnoverMonths": 1
}{
"address": "경기도 성남시",
"ceo_name": "남기연",
"certificate": [
{
"cert_number": "20100300166",
"changes": "",
"disclosure_date": "2010-06-10",
"first_cert_date": "2010-06-10",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2010-06-10 ~ 2012-06-09"
},
{
"cert_number": "20120300207",
"changes": "",
"disclosure_date": "2012-06-21",
"first_cert_date": "2010-06-10",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2012-06-10 ~ 2014-06-09"
},
{
"cert_number": "20140300273",
"changes": "",
"disclosure_date": "2014-07-24",
"first_cert_date": "2010-06-10",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2014-07-24 ~ 2016-07-23"
},
{
"cert_number": "20160300330",
"changes": "",
"disclosure_date": "2016-07-07",
"first_cert_date": "2010-06-10",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2016-07-24 ~ 2018-07-23"
},
{
"cert_number": "20180300542",
"changes": "",
"disclosure_date": "2018-07-26",
"first_cert_date": "2010-06-10",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2018-07-24 ~ 2020-07-23"
},
{
"cert_number": "20200402349",
"changes": "",
"disclosure_date": "2020-10-15",
"first_cert_date": "2010-06-10",
"no": "6",
"type": "연구개발유형",
"valid_period": "2020-07-24 ~ 2022-07-23"
},
{
"cert_number": "20220713010002",
"changes": "",
"disclosure_date": "2022-07-13",
"first_cert_date": "2010-06-10",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2022-07-24 ~ 2025-07-23"
},
{
"cert_number": "20250715010016",
"changes": "",
"disclosure_date": "2025-07-15",
"first_cert_date": "2010-06-10",
"no": "8",
"type": "벤처투자유형",
"valid_period": "2025-07-24 ~ 2028-07-23"
}
],
"company_name": "주식회사 큐리언트",
"financials": {
"2022": {
"capital_stock": 6430583000,
"cost_of_sales": 10118840000,
"current_assets": 24054755000,
"current_liabilities": 2795807000,
"gross_profit": 2064006000,
"net_income": -22683446000,
"net_income_bs": -22683447000,
"non_current_assets": 8433777000,
"non_current_liabilities": 323163000,
"non_operating_expenses": 694139000,
"non_operating_income": 1028508000,
"operating_profit": -23017815000,
"revenue": 12182846000,
"sga_expenses": 25081821000,
"total_assets": 32488532000,
"total_equity": 29369562000,
"total_liabilities": 3118970000
},
"2023": {
"capital_stock": 14080839000,
"cost_of_sales": 9451990000,
"current_assets": 36388321000,
"current_liabilities": 2168300000,
"gross_profit": 2283214000,
"net_income": -19536136000,
"net_income_bs": -19536137000,
"non_current_assets": 12370995000,
"non_current_liabilities": 284185000,
"non_operating_expenses": 185263000,
"non_operating_income": 704037000,
"operating_profit": -20054910000,
"revenue": 11735204000,
"sga_expenses": 22338125000,
"total_assets": 48759317000,
"total_equity": 46306832000,
"total_liabilities": 2452485000
},
"2024": {
"capital_stock": 17112718000,
"cost_of_sales": 9355819000,
"current_assets": 44376514000,
"current_liabilities": 4965616000,
"gross_profit": 1655235000,
"net_income": -22330511000,
"net_income_bs": -22330512000,
"non_current_assets": 19200349000,
"non_current_liabilities": 371908000,
"non_operating_expenses": 287756000,
"non_operating_income": 3083592000,
"operating_profit": -25126347000,
"revenue": 11011053000,
"sga_expenses": 26781582000,
"total_assets": 63576863000,
"total_equity": 58239339000,
"total_liabilities": 5337525000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "7,499,999,780",
"changes": "7,499,999,780",
"date": "2024-07-29"
},
{
"amount": "9,500,000,000",
"changes": "9,500,000,000",
"date": "2021-12-17"
},
{
"amount": "1,970,832,000",
"changes": "1,970,832,000",
"date": "2014-06-10"
}
],
"phone": "031-8060-****",
"source": "pg_migration"
}{
"address": "경기도 성남시 분당구 판교로 242 8층 (피디씨씨타워 C동)",
"employee_count": 33,
"establishment_date": "20091015",
"source": "pg_migration",
"workplace_name": "주식회사큐리언트"
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| comwel_insurance | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |